Report on assessment of surgical procedures for the treatment of obesity released by EUnetHTA

02

Sep 2021

At the beginning of August 2021, the European Network for Health Technology Assessment, EUnetHTA, released a final report on the surgical procedures for the treatment of obesity. The evaluation was aimed to determine the comparative effectiveness and potential superiority of different bariatric procedures for the treatment of adult obesity in improving outcomes of importance for patients with weight loss, diabetes control, etc.

The following key conclusions are provided:

  • The results suggest little or no difference in the effects of different bariatric surgery procedures on weight loss and diabetes control. However, the results are based mainly on low to very low certainty evidence, with few or even single studies providing data for many of the comparisons;
  • No evidence was found for the effectiveness of the more recent single anastomosis duodenal-ileal bypass with sleeve gastrectomy or single anastomosis sleeve ileal bypass procedures;
  • No study reported on patient satisfaction with the procedure;
  • More high-quality research is needed to determine the relative effect of most obesity surgery procedures, as results for many comparisons are based on data from few studies at high risk of bias;
  • There is a need for studies with longer follow-up in order to assess the long-term effects of obesity surgery;
  • There is a need for standardized definitions, uniform classifications of adverse events, and reporting standards in this field of research to improve the evidence base.

The full details in English can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

20

Jan 2023

In December 2022, the National Institute for Health and Care Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned laser therapy in diabetic macular oedema, EarlyCDT Lung blood test, video-assisted thoracoscopic or open lobectomy, urethral slings for stress urinary incontinence, placental growth factor (PlGF) and sFlt-1 tests, and photobiomodulation in the management of oral mucositis. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more

12

Jan 2023

In December 2022, the National Institute for Health and Care Excellence (NICE) published one new Medical Technologies Guidance (Memokath 051 Ureter stent for ureteric obstruction) and one MedTech Innovation Briefing (PromarkerD). Also, two new clinical guidelines were published, and one was updated.

Read more

04

Jan 2023

In the second half of December 2022, the Basque Office for Health Technology Assessment (OSTEBA) released a report aiming to evaluate mitral valve repair surgery as an alternative to mitral valve replacement.

Read more

22

Dec 2022

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 24486 of December 7, 2022, Tuscany Regional Healthcare has published assessments of three medical devices in the surgical procedures, neurology and neurosurgery, and extracorporeal treatments areas.

Read more

21

Dec 2022

On November 25, 2022, the Treatment Council (Behandlingsråd) announced the third topic selected for major analyses (større analyser) for 2023. The selected topic is regarding the non-invasive treatment of obstructive sleep apnea.

Read more